Market Cap ₹204 Cr.
Stock P/E 21.3
P/B 2.6
Current Price ₹150.6
Book Value ₹ 59
Face Value 10
52W High ₹215.1
Dividend Yield 0.13%
52W Low ₹ 145
Mitsu Chem Plast Ltd. is a manufacturer of injection and plastic blow molded products. The Company manufactures a variety of products inside the blow molding, injection molding and additionally customized molding (mixture of procedures). The Company's products are categorised as Molded Industrial Packaging, Healthcare Furniture, Automotive Components and Infrastructural Furniture. Under Molded Industrial Packaging, it gives complete open top drum, jerry cans, narrow mouth drums, wide mouth drums/jars, large variety of small packing containers, injection molded solutions and sports merchandise. Under Healthcare Furniture, it offers Plastic Rod, Plastic Buffers, Plastic Toilet Seat, Plastic Food Table Board, Curved Head and Leg Bow, Plastic Straight Head and Foot Bow, Side Railing with Bracket and Head Immobilizer. Under Infrastructural Furniture, it offers Plastic Stadium Seat, Plastic Chair Seats, Plastic Chair Parts, Plastic Chair Shells, Plastic Seat Shells, and Plastic Baby Car Seat Shell.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 66 | 75 | 85 | 70 | 72 | 83 | 80 | 76 | 73 | 82 |
Other Income | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
Total Income | 66 | 75 | 85 | 70 | 72 | 83 | 80 | 76 | 74 | 83 |
Total Expenditure | 61 | 66 | 75 | 65 | 66 | 76 | 75 | 70 | 66 | 75 |
Operating Profit | 5 | 8 | 10 | 5 | 5 | 8 | 5 | 6 | 8 | 8 |
Interest | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 3 | 6 | 7 | 2 | 2 | 4 | 2 | 2 | 4 | 4 |
Provision for Tax | 1 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Profit After Tax | 2 | 3 | 5 | 2 | 2 | 3 | 1 | 2 | 3 | 3 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 |
Profit After Adjustments | 2 | 3 | 5 | 2 | 2 | 3 | 1 | 2 | 3 | 3 |
Adjusted Earnings Per Share | 1.6 | 2.7 | 4.1 | 1.2 | 1.5 | 2.7 | 1.1 | 1.2 | 2.6 | 2.2 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 70 | 80 | 88 | 89 | 94 | 112 | 125 | 139 | 178 | 258 | 309 | 311 |
Other Income | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
Total Income | 70 | 81 | 88 | 89 | 95 | 113 | 125 | 139 | 179 | 259 | 311 | 313 |
Total Expenditure | 63 | 73 | 81 | 81 | 86 | 103 | 114 | 123 | 155 | 232 | 284 | 286 |
Operating Profit | 7 | 8 | 7 | 9 | 9 | 10 | 11 | 16 | 24 | 27 | 27 | 27 |
Interest | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 6 | 6 | 6 | 7 | 8 |
Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 5 | 5 | 6 |
Exceptional Income / Expenses | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 2 | 2 | 1 | 3 | 3 | 4 | 4 | 6 | 14 | 16 | 15 | 12 |
Provision for Tax | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 4 | 5 | 3 | 3 |
Profit After Tax | 2 | 2 | 1 | 2 | 2 | 3 | 4 | 4 | 10 | 12 | 12 | 9 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 2 | 2 | 1 | 2 | 2 | 3 | 4 | 4 | 10 | 12 | 12 | 9 |
Adjusted Earnings Per Share | 1.3 | 1.4 | 0.6 | 1.8 | 2.2 | 2.9 | 2.9 | 3.2 | 7.8 | 9.3 | 9.5 | 7.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 20% | 31% | 23% | 16% |
Operating Profit CAGR | 0% | 19% | 22% | 14% |
PAT CAGR | 0% | 44% | 32% | 20% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -25% | -13% | 22% | NA% |
ROE Average | 21% | 25% | 21% | 20% |
ROCE Average | 17% | 19% | 17% | 16% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 9 | 10 | 10 | 12 | 13 | 22 | 27 | 30 | 40 | 51 | 62 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 11 | 13 | 16 | 15 | 13 | 14 | 28 | 28 | 32 | 29 | 38 |
Other Non-Current Liabilities | 1 | 2 | 2 | 2 | 2 | 6 | 5 | 5 | 5 | 6 | 7 |
Total Current Liabilities | 18 | 21 | 27 | 28 | 28 | 27 | 41 | 45 | 50 | 62 | 74 |
Total Liabilities | 39 | 46 | 56 | 56 | 56 | 69 | 99 | 109 | 127 | 148 | 181 |
Fixed Assets | 17 | 20 | 21 | 22 | 24 | 26 | 57 | 59 | 60 | 62 | 72 |
Other Non-Current Assets | 1 | 1 | 1 | 1 | 1 | 7 | 2 | 3 | 4 | 3 | 16 |
Total Current Assets | 21 | 25 | 33 | 33 | 31 | 37 | 40 | 46 | 62 | 82 | 92 |
Total Assets | 39 | 46 | 56 | 56 | 56 | 69 | 99 | 109 | 127 | 148 | 181 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 1 | 0 | 5 | 0 | 1 | 0 | 0 | 1 | 2 |
Cash Flow from Operating Activities | 4 | 6 | 5 | 14 | 4 | 6 | 18 | 4 | 13 | 7 | 22 |
Cash Flow from Investing Activities | -3 | -4 | -3 | -4 | -4 | -7 | -30 | -8 | -8 | -3 | -27 |
Cash Flow from Financing Activities | -1 | -1 | -2 | -5 | -6 | 2 | 11 | 3 | -5 | -2 | 3 |
Net Cash Inflow / Outflow | 0 | 0 | 1 | 5 | -5 | 1 | -1 | -0 | -0 | 1 | -2 |
Closing Cash & Cash Equivalent | 1 | 1 | 2 | 5 | 0 | 1 | 0 | 0 | 0 | 2 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.33 | 1.35 | 0.56 | 1.75 | 2.24 | 2.9 | 2.89 | 3.2 | 7.79 | 9.25 | 9.5 |
CEPS(Rs) | 2.47 | 2.68 | 2.23 | 3.45 | 4.05 | 4.41 | 4.86 | 6.42 | 11.35 | 13.13 | 13.75 |
DPS(Rs) | 0.49 | 1.2 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.2 | 0.2 | 0.2 | 0.2 |
Book NAV/Share(Rs) | 6.55 | 7.73 | 8.03 | 9.42 | 11.65 | 18.13 | 21.36 | 24.28 | 31.9 | 40.97 | 50.22 |
Core EBITDA Margin(%) | 9.62 | 8.56 | 6.99 | 7.86 | 7.54 | 8.56 | 8.45 | 11.44 | 12.95 | 9.96 | 8.2 |
EBIT Margin(%) | 8.29 | 7.83 | 5.68 | 6.44 | 6.35 | 7.21 | 6.69 | 8.78 | 11.1 | 8.54 | 7.01 |
Pre Tax Margin(%) | 3.26 | 3.03 | 1.17 | 2.51 | 2.91 | 3.87 | 3.46 | 4.2 | 7.74 | 6.37 | 4.8 |
PAT Margin (%) | 2.3 | 2 | 0.75 | 1.84 | 2.18 | 3.09 | 2.88 | 2.87 | 5.43 | 4.46 | 3.82 |
Cash Profit Margin (%) | 3.86 | 3.58 | 2.37 | 3.62 | 3.95 | 4.71 | 4.84 | 5.76 | 7.91 | 6.33 | 5.53 |
ROA(%) | 4.67 | 3.86 | 1.51 | 3.42 | 4.34 | 5.54 | 4.26 | 3.82 | 8.22 | 8.36 | 7.19 |
ROE(%) | 25.27 | 20.97 | 8.91 | 20.09 | 21.25 | 20.18 | 14.87 | 14.02 | 27.75 | 25.4 | 20.83 |
ROCE(%) | 19.25 | 17.48 | 13.26 | 13.99 | 15.04 | 15.61 | 12.17 | 13.95 | 20.03 | 19.85 | 16.82 |
Receivable days | 58.99 | 65.81 | 63.69 | 66.06 | 58.9 | 64.72 | 65.65 | 68.33 | 59.04 | 50 | 52.37 |
Inventory Days | 24.98 | 26.02 | 28.76 | 29.49 | 25.51 | 30.86 | 30.68 | 30.47 | 35.82 | 36.7 | 36.25 |
Payable days | 11.01 | 12.49 | 16.93 | 24.22 | 25.12 | 19.39 | 30.67 | 35.98 | 28.72 | 28.08 | 34.36 |
PER(x) | 0 | 0 | 0 | 0 | 25.46 | 15.87 | 19.17 | 20.8 | 13.71 | 26.32 | 14.9 |
Price/Book(x) | 0 | 0 | 0 | 0 | 4.89 | 2.54 | 2.59 | 2.74 | 3.35 | 5.95 | 2.82 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0.28 | 0.35 | 0.29 | 0.29 | 0.18 | 0.08 | 0.14 |
EV/Net Sales(x) | 0.39 | 0.39 | 0.45 | 0.34 | 1 | 0.77 | 0.97 | 1.04 | 1.08 | 1.43 | 0.82 |
EV/Core EBITDA(x) | 3.97 | 4.09 | 5.26 | 3.59 | 10.35 | 8.71 | 11.19 | 8.91 | 7.93 | 13.71 | 9.38 |
Net Sales Growth(%) | 34.11 | 14.52 | 10.06 | 1.04 | 6 | 19.23 | 11.13 | 11.05 | 28.72 | 44.51 | 19.89 |
EBIT Growth(%) | 28.39 | 10.63 | -9.19 | 14.85 | 6.26 | 14.23 | 3.14 | 45.67 | 62.62 | 11.23 | -1.55 |
PAT Growth(%) | 24.5 | 1.44 | -53.1 | 149.66 | 27.66 | 42.5 | 3.4 | 10.72 | 143.72 | 18.7 | 2.65 |
EPS Growth(%) | 2.49 | 1.59 | -58.68 | 213.16 | 27.66 | 29.45 | -0.3 | 10.72 | 143.71 | 18.7 | 2.65 |
Debt/Equity(x) | 2.9 | 2.95 | 3.68 | 2.99 | 2.72 | 1.58 | 2.04 | 2.11 | 1.61 | 1.32 | 1.23 |
Current Ratio(x) | 1.18 | 1.18 | 1.21 | 1.21 | 1.12 | 1.38 | 1 | 1.02 | 1.23 | 1.32 | 1.25 |
Quick Ratio(x) | 0.87 | 0.88 | 0.85 | 0.96 | 0.81 | 0.99 | 0.73 | 0.74 | 0.79 | 0.85 | 0.82 |
Interest Cover(x) | 1.65 | 1.63 | 1.26 | 1.64 | 1.85 | 2.16 | 2.07 | 1.92 | 3.31 | 3.93 | 3.17 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.56 | 0.62 | 0.79 | 0.77 | 0.48 | 0.22 | 0.44 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 73.03 | 73.03 | 73.03 | 73.03 | 73.03 | 73.03 | 73.03 | 73.03 | 73.03 | 67.75 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 1.92 | 1.81 | 1.81 | 1.07 | 1.07 | 1 | 0.38 | 0 | 0 | 0 |
Public | 25.06 | 25.17 | 25.17 | 25.9 | 25.9 | 25.97 | 26.6 | 26.97 | 26.97 | 32.25 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | 0.92 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
Public | 0.3 | 0.3 | 0.3 | 0.31 | 0.31 | 0.31 | 0.32 | 0.33 | 0.33 | 0.44 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.21 | 1.36 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About